TG
Highly rated in
22
conditions
Highly rated in
22
conditions
Check Dr. Thomas J. Galloway's experience treating your condition:
About Dr. Thomas J. Galloway

Thomas Galloway is a Radiation Oncologist in Philadelphia, Pennsylvania. Galloway has been practicing medicine for over 17 years and is highly rated in 22 conditions, according to our data. His top areas of expertise are Tongue Cancer, Oral Squamous Cell Carcinoma, Laryngeal Cancer, and Head and Neck Squamous Cell Carcinoma HNSCC. He is licensed to treat patients in Florida and Pennsylvania. Galloway is currently accepting new patients.

His clinical research consists of co-authoring 76 peer reviewed articles and participating in 12 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Thomas J. Galloway it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Thomas J. Galloway accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
Locations
333 Cottman Ave, Philadelphia, PA 19111
Background & Education
Graduate Institution
University Of Florida College Of Medicine, 2005
Specialties
Radiation Oncology
Licenses
Radiology in FL
Hospital Affiliations
Temple University Hospital - Jeanes Campus
Temple University Hospital
Fox Chase Cancer Center
Languages Spoken
English
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


12 Clinical Trials

Randomized Phase II/III Trial of Adjuvant Radiation Therapy With Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features
Phase II Randomized Trial of Radiotherapy With or Without Cisplatin for Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN) With TP53 Sequencing
A Phase II Trial of Reirradiation Combined With Open Label Pembrolizumab in Patients With Locoregional Inoperable Recurrence or Second Primary Squamous Cell Carcinoma of the Head and Neck (SCCHN)
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase I and Expansion Cohort Study of Adjuvant Cisplatin, Intensity-Modulated Radiotherapy, and MK-3475 (Pembrolizumab) in High-Risk Head and Neck Squamous Cell Carcinoma (HNSCC)
TRYHARD: A Phase II, Randomized, Double Blind, Placebo-Controlled Study of Lapatinib (Tykerb®) for Non-HPV Locally Advanced Head and Neck Cancer With Concurrent Chemoradiation
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
View 6 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors